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Asia-Pacific regionEnteroviruses (EV), the major pathogens of hand, foot, and mouth disease (HFMD) and herpangina, affect
millions of children each year. Most human enteroviruses cause self-limited infections except polio-
viruses, enterovirus A71 (EV-A71), enterovirus D68 (EV-D68), and several echoviruses (Echo) and cox-
sackieviruses (CV). Especially, EV-A71 has repeatedly caused large-scale outbreaks in the Asia-Pacific
region since 1997. Some Asian countries have experienced cyclical outbreaks of severe EV-A71 infections
and initiated development of EV-A71 vaccines. Five EV-A71 vaccine candidates have been clinically eval-
uated and three of them were approved for marketing in China. However, none of the China-approved
products seek marketing approval in other countries.
This situation supports a role for collaboration among Asian countries to facilitate clinical trials and
licensure of EV-A71 vaccines. Additionally, enterovirus D68 outbreaks have been reported in the US
and Taiwan currently and caused severe complications and deaths. Hence, an Asia-Pacific Network for
Enterovirus Surveillance (APNES) has been established to estimate disease burden, understand virus evo-
lution, and facilitate vaccine development through harmonizing laboratory diagnosis and data collection.
Founded in 2017, the APNES is comprised of internationally recognized experts in the field of enterovirus
in Asian countries working to raise awareness of this potentially fatal and debilitating disease. This article
demonstrated the summaries of the first expert meeting, 2017 International Workshop on Enterovirus
Surveillance and Vaccine Development, held by APNES in Taipei, Taiwan, March 2017.1. Introduction
Enteroviruses (EV), the major pathogens of hand, foot, and
mouth disease (HFMD) and herpangina, affect millions of people
each year worldwide, especially among infants and young children
[1–3]. The genus Enterovirus belongs to the family Picornaviridae
and consists of 13 species, including four species causing human
infections (Enterovirus species A ~ D). Human EV could be classified
into more than 100 serotypes. Most human enteroviruses cause
self-limited infections except polioviruses, enterovirus A71 (EV-
A71), enterovirus D68 (EV-D68), and several echoviruses (Echo)
and coxsackieviruses (CV) which could result into neurologicalcomplications. Especially, EV-A71 has repeatedly caused large-
scale outbreaks of severe HFMD in the Asia-Pacific region since
1997 [4]. The rapid progression of severe complications, such as
central nervous system disease and cardiopulmonary failure, can
lead to death within 24 to 48 hours [5]. The overall household
transmission rate of EV-A71 was 52%, and particularly high at
84% among children under 6 years of age [6]. Patients with uncom-
plicated EV illness bring significant economic and medical impacts
on society with at least 1–4 days of missed school or lost work, and
direct medical costs of $69–771 USD per case and indirect costs of
$63–422 USD per case mainly attributable to parental missed work
[7].
EV-A71, one of the EV-A viruses, is the major etiologic agent of
HFMD and herpangina. Based on phylogenetic analysis of VP1
genes, EV-A71 viruses are divided into 8 genogroups A to Hoi.org/
